Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction

Y. Kitamura, Y. Matsuka, I. Spigelman, Yoshihito Ishihara, Y. Yamamoto, W. Sonoyama, T. Kuboki, K. Oguma

Research output: Contribution to journalArticlepeer-review

67 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction'. Together they form a unique fingerprint.

Medicine & Life Sciences